NEW YORK (GenomeWeb News) – Danish small-molecule lead discovery firm Nuevolution today announced it has raised DKK 80.5 million ($13.7 million).

Proceeds will go toward expansion of Nuevolution's operations directed at identifying small molecule lead compounds against "therapeutically important high value targets," it said. Industrifonden led the financing round. Other participants include Sunstone Capital, SEB Venture Capital, and SEB Utvecklingsstiftelse.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.